Showcasing Breakthrough Technologies for Active Compounds Value Creation
April 26th, 2012, 3pm - 5pm
(followed by a wine and cheese networking reception)
TRI Princetoin Campus, 601 Prospect Ave, Princeton, NJ
Kindly RSVP by April 24th to Dina Walker, 609-430-4828 or dwalker@triprinceton.org
Agenda
DermaNest & TRI Center for Skin Science & Applied Dermatology Dr. Mathieu Petitjean and Dr. Michael Drzewinski
An introduction to the mission and capabilities of DermaNest, the TRI Center for Skin Science & Applied Dermatology, and the International Institute for Dermatology.
2D+ : Innovation in Cell Culturing Technology (Cytoo) Dr. Lisa Minor
This innovative 2D+ technology enables major improvements in culturing cells to increase assay reproducibility and reliability while improving the capacity to achieve a more physiological phenotype in cells cultured on 2D surfaces without resorting to a 3D culture system. Since each micro-pattern is identical (hundreds per well), cells perform in a reproducible and consistent manner decreasing the use of primary cells and permitting less replicates per data point. (www.cytoo.com)
SDG a 3-Dimensional Network that Incorporates and Stabilizes Multiple Drugs of Various Physicochemical Properties (Agigma) Dr. Nena Gulobovic-Liakopoulos
This unique topical and trans-dermal technology platform enables the development of formulations that are cosmetically attractive while incorporating, stabilizing, and releasing multiple actives or drugs. For pharmaceutical applications it enables the formulation of drug combinations that have not previously been possible generating possibilities to re-purpose products that have previously been used for the treatment of other diseases and/or have not been available for dermal line extensions.
No comments:
Post a Comment